IART — INTEGRA LIFESCIENCES HOLDINGS CORP
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 917520 ·
Last close
$16.12
Market Cap
$1.25B
52W High
$20.49
52W Low
$8.70
ADV30
784,000
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 418,761,000 | 219,744,000 | 19,285,000 | 4,482,000 | 3,563,490,000 | 214,415,000 | 2,520,113,000 |
| Mar 2026 | 391,918,000 | 216,982,000 | 11,470,000 | -4,617,000 | 3,577,726,000 | 236,809,000 | 2,535,320,000 |
| Dec 2025 | 434,925,000 | 220,865,000 | 23,040,000 | -1,704,000 | 3,602,001,000 | 235,048,000 | 2,558,538,000 |
| Sep 2025 | 402,062,000 | 206,991,000 | 11,761,000 | -5,404,000 | 3,646,452,000 | 232,186,000 | 2,608,878,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$85,327,000
Investing CF
$-108,626,000
Financing CF
$21,576,000
CapEx
$-73,727,000
Dividends Paid
—
Buybacks
$-2,471,000
EPS Diluted TTM
$-0.09
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$423,306,000
Inventory
$492,005,000
Receivables
$267,188,000
ST Investments
$59,669,000
EBIT TTM
$91,678,000
Pretax Income TTM
$-179,000
Interest Exp TTM
$91,857,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,647,666,048
EBITDA
$316,918,016
Free Cash Flow
$94,402,000
Enterprise Value
$2,981,507,840
Total Cash
$274,084,000
Total Debt
$2,050,118,016
Shares Out
77,772,506
Trailing EPS
$-0.09
Book Value
$13.41
ROE
-0.7%
ROA
2.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,635,245,000 | 17,995,000 | -516,474,000 | 3,602,001,000 | 2,558,538,000 | 1,043,463,000 | 50,384,000 |
| Dec 2024 | 1,610,527,000 | 28,411,000 | -6,944,000 | 4,037,424,000 | 2,492,144,000 | 1,545,280,000 | 129,382,000 |
| Dec 2023 | 1,541,573,000 | 111,526,000 | 67,741,000 | 3,781,988,000 | 2,194,104,000 | 1,587,884,000 | 139,955,000 |
| Dec 2022 | 1,557,666,000 | 238,920,000 | 180,550,000 | 3,889,758,000 | 2,085,355,000 | 1,804,403,000 | 264,469,000 |
TTM Snapshot
Revenues TTM
$1,531,099,000
NetIncome TTM
$33,424,000
OpCashFlow TTM
$0
Assets (Latest)
$3,602,001,000
Forward EPS
$2.61
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $15.94 · call volume: 162 · put volume: 5
Expected Move to 2026-10-16:
±$1.95
(12.26%) —
implied range
$13.98 –
$17.89
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DRTS | Alpha Tau Medical Ltd. | $1.34B | $14.54 | — |
| CNMD | CONMED Corp | $1.36B | $45.38 | — |
| CDRE | Cadre Holdings, Inc. | $1.13B | $26.39 | — |
| AORT | ARTIVION, INC. | $1.10B | $22.63 | — |
| IRMD | IRADIMED CORP | $1.10B | $85.76 | — |
News headlines (Yahoo Finance, 1h cache)
Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026
2026-09-25 13:05 · Yahoo
Integra LifeSciences (IART) Stock May Be 48% Undervalued On Cash Flow
2026-09-23 06:15 · Yahoo
Q2 Earnings Outperformers: Integra LifeSciences (NASDAQ:IART) And The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
2026-09-10 21:37 · Yahoo
Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference
2026-09-04 13:15 · Yahoo
Is IART Still Attractive as Its Low Valuation Meets Execution Risks?
2026-08-19 15:35 · Yahoo
Integra (IART) Q2 2026 Earnings Call Transcript
2026-08-08 01:03 · Yahoo
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call
2026-08-07 12:05 · Yahoo
Integra LifeSciences Holdings (IART) Returns To Profit As Fair Value Debate Stays In Focus
2026-08-03 03:16 · Yahoo
Why Integra LifeSciences (IART) Trimmed Its 2026 Outlook After Returning to Profitability
2026-08-02 14:08 · Yahoo
IART Q2 Deep Dive: Flat Revenue, Margin Pressure, and Operational Realignment Shape Outlook
2026-08-01 16:43 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.